Prise en charge de la BPCO Mise à jour, Rev Mal Respir, vol.27, pp.522-570, 2009. ,
Global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010 Available from: http://www.goldcopd.org, 2011. ,
Caract??ristiques et prise en charge des exacerbations aigu??s de BPCO hospitalis??es. ??tude EABPCO???CPHG du Coll??ge des pneumologues des h??pitaux g??n??raux, Revue des Maladies Respiratoires, vol.27, issue.1, pp.19-29, 2010. ,
DOI : 10.1016/j.rmr.2009.11.007
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease, Thorax, vol.57, issue.10, pp.847-52, 2002. ,
DOI : 10.1136/thorax.57.10.847
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease, Thorax, vol.60, issue.11, pp.925-956, 2005. ,
DOI : 10.1136/thx.2005.040527
COPD exacerbations {middle dot} 1: Epidemiology, Thorax, vol.61, issue.2, pp.164-172, 2006. ,
DOI : 10.1136/thx.2005.041806
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease, New England Journal of Medicine, vol.363, issue.12, pp.1128-1166, 2010. ,
DOI : 10.1056/NEJMoa0909883
Global burden of COPD: systematic review and meta-analysis, European Respiratory Journal, vol.28, issue.3, pp.523-532, 2006. ,
DOI : 10.1183/09031936.06.00124605
Epidemiology of chronic obstructive pulmonary disease: a literature review, International Journal of Chronic Obstructive Pulmonary Disease, vol.7, pp.457-94, 2012. ,
DOI : 10.2147/COPD.S32330
International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study, The Lancet, vol.370, issue.9589, pp.741-750, 2007. ,
DOI : 10.1016/S0140-6736(07)61377-4
Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study, The Lancet, vol.366, issue.9500, pp.1875-1881, 2005. ,
DOI : 10.1016/S0140-6736(05)67632-5
An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages, Thorax, vol.59, issue.2, pp.120-125, 2004. ,
DOI : 10.1136/thorax.2003.011163
??pid??miologie descriptive de la bronchopneumopathie chronique obstructive (BPCO) en France, Revue des Maladies Respiratoires, vol.27, issue.2, pp.160-168, 2010. ,
DOI : 10.1016/j.rmr.2009.08.003
Mortalité liée à la BPCO en France métropolitaine entre, BEH thématique, pp.27-35, 2003. ,
50-Year Trends in Smoking-Related Mortality in the United States, New England Journal of Medicine, vol.368, issue.4, pp.351-64, 2013. ,
DOI : 10.1056/NEJMsa1211127
Alternative projections of mortality and disability by cause 1990???2020: Global Burden of Disease Study, The Lancet, vol.349, issue.9064, pp.1498-1504, 1997. ,
DOI : 10.1016/S0140-6736(96)07492-2
Burden and clinical features of chronic obstructive pulmonary disease (COPD), The Lancet, vol.364, issue.9434, pp.613-620, 2004. ,
DOI : 10.1016/S0140-6736(04)16855-4
Impact ??conomique de la BPCO en France : ??tude SCOPE, Revue des Maladies Respiratoires, vol.22, issue.2, pp.247-55, 2005. ,
DOI : 10.1016/S0761-8425(05)85478-6
Chronic obstructive pulmonary disease in non-smokers, The Lancet, vol.374, issue.9691, pp.733-743 ,
DOI : 10.1016/S0140-6736(09)61303-9
Indoor air pollution from biomass combustion and acute respiratory infections in Kenya: an exposure-response study, The Lancet, vol.358, issue.9282, pp.619-624, 2001. ,
DOI : 10.1016/S0140-6736(01)05777-4
Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China, Thorax, vol.62, issue.10, pp.889-897, 2007. ,
DOI : 10.1136/thx.2006.061457
Genetics of COPD, Chest, vol.125, issue.5, pp.1929-1940, 2004. ,
DOI : 10.1378/chest.125.5.1929
Estimated numbers and prevalence of PI*S and PI*Z alleles of ??1-antitrypsin deficiency in European countries, European Respiratory Journal, vol.27, issue.1, pp.77-84, 2006. ,
DOI : 10.1183/09031936.06.00062305
??1-antitrypsin deficiency, The Lancet, vol.365, issue.9478, pp.2225-2236, 2005. ,
DOI : 10.1016/S0140-6736(05)66781-5
Can Disease Management Target Patients Most Likely to Generate High Costs? The Impact of Comorbidity, Journal of General Internal Medicine, vol.39, issue.11, pp.464-473, 2007. ,
DOI : 10.1007/s11606-007-0130-7
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD, European Respiratory Journal, vol.32, issue.4, pp.962-969, 2008. ,
DOI : 10.1183/09031936.00012408
Clinical COPD phenotypes: a novel approach using principal component and cluster analyses, Eur Respir J, vol.36, pp.531-540, 2010. ,
CT phenotype correlates with health status and BODE in COPD, Eur Respir J, vol.36, pp.5551-5585, 2010. ,
Physiopathologie de la bronchopneumopathie chronique obstructive, EMC - Pneumologie, vol.9, issue.1, pp.1-12 ,
DOI : 10.1016/S1155-195X(12)70003-8
Chronic obstructive pulmonary disease, The Lancet, vol.379, issue.9823, pp.1341-51, 2012. ,
DOI : 10.1016/S0140-6736(11)60968-9
Small Airways in COPD, New England Journal of Medicine, vol.350, issue.26, pp.2635-2637, 2004. ,
DOI : 10.1056/NEJMp048102
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease, New England Journal of Medicine, vol.350, issue.26, pp.2645-2653, 2004. ,
DOI : 10.1056/NEJMoa032158
The natural history of chronic airflow obstruction., BMJ, vol.1, issue.6077, pp.1645-1653, 1977. ,
DOI : 10.1136/bmj.1.6077.1645
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study, JAMA: The Journal of the American Medical Association, vol.272, issue.19, pp.1497-505, 1994. ,
DOI : 10.1001/jama.272.19.1497
The Efficacy of Influenza Vaccine in Elderly Persons, Annals of Internal Medicine, vol.123, issue.7, pp.518-545, 1995. ,
DOI : 10.7326/0003-4819-123-7-199510010-00008
Acute Respiratory Illness in Patients With COPD and the Effectiveness of Influenza Vaccination, Chest, vol.125, issue.6, pp.2011-2031, 2004. ,
DOI : 10.1378/chest.125.6.2011
The clinical management in extremely severe COPD, Respiratory Medicine, vol.101, issue.8, pp.1613-1624, 2007. ,
DOI : 10.1016/j.rmed.2007.02.011
Indications de la réhabilitation respiratoire chez le BPCO, Rev Mal Respir, vol.22, pp.7-17, 2005. ,
Rehabilitation in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.172, pp.19-38, 2005. ,
DOI : 10.1183/1025448x.00038021
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease, New England Journal of Medicine, vol.359, issue.15, pp.1543-54, 2008. ,
DOI : 10.1056/NEJMoa0805800
Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease, Thorax, vol.60, issue.4, pp.301-305, 2005. ,
DOI : 10.1136/thx.2004.025411
Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD, Eur Respir J Chest, vol.5130, issue.52, pp.659-64647, 1992. ,
Prise en charge de la BPCO en pneumologie selon le stade de s??v??rit??, Revue des Maladies Respiratoires, vol.26, issue.9, pp.933-974, 2009. ,
DOI : 10.1016/S0761-8425(09)73328-5
Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns, International Journal of Chronic Obstructive Pulmonary Disease, vol.2014, pp.9889-905 ,
DOI : 10.2147/COPD.S62750
Depression in the patient with COPD, International Journal of COPD, vol.1, issue.1, pp.61-64, 2006. ,
DOI : 10.2147/copd.2006.1.1.61
Canadian Practice Assessment in Chronic Obstructive Pulmonary Disease: Respiratory Specialist Physician Perception Versus Patient Reality, Canadian Respiratory Journal, vol.20, issue.2, pp.97-105, 2013. ,
DOI : 10.1155/2013/369019
Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany, International Journal of Chronic Obstructive Pulmonary Disease, vol.7, pp.101-108, 2012. ,
DOI : 10.2147/COPD.S27887
Adherence to the Swiss quidelines for management of COPD : Experience of a Swiss teaching hospital, Swiss Med Wkly, vol.135, pp.116-137, 2005. ,
Inhaled corticosteroids in COPD and the risk of serious pneumonia, Thorax, vol.183, issue.(2), pp.1029-1036, 2013. ,
DOI : 10.1136/thoraxjnl-2012-202872
Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD Prim, Care Respir J, vol.22, issue.1, pp.92-100, 2013. ,
The Reality of Drug Use in COPD, Chest, vol.117, issue.2, pp.29-32, 2000. ,
DOI : 10.1378/chest.117.2_suppl.29S
Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians, International Journal of Chronic Obstructive Pulmonary Disease, vol.6, pp.171-179, 2011. ,
DOI : 10.2147/COPD.S16396
A 6-Month, Placebo-Controlled Study Comparing Lung Function and Health Status Changes in COPD Patients Treated With Tiotropium or Salmeterol, Chest, vol.122, issue.1, pp.47-55, 2002. ,
DOI : 10.1378/chest.122.1.47
A Short-Term Comparison of Fluticasone Propionate/Salmeterol with Ipratropium Bromide/Albuterol for the Treatment of COPD, Treatments in Respiratory Medicine, vol.261, issue.22, pp.173-181, 2004. ,
DOI : 10.2165/00151829-200403030-00005
Qualit?? des soins dans le domaine de la BPCO, Revue des Maladies Respiratoires, vol.23, issue.3, pp.6-44, 2006. ,
DOI : 10.1016/S0761-8425(06)71587-X